Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial

Skye Marshall, Elisabeth Isenring, Anna Elizabeth Lohning, Andy Koh, Alexandra L. McCarthy, Alex Molassiotis, Robert Bird, Ian McPherson, Catherine Shannon, Wolfgang Marx

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Abstract

Introduction
Research is required to explore whether ginger-mediated improvements
in chemotherapy-induced nausea and vomiting (CINV) translate into improved
quality of life (QoL). This trial assessed the efficacy (CINV incidence/
severity, QoL) and safety of a ginger supplement in adults undergoing
chemotherapy (CTX).
Original languageEnglish
Article numberANTIE-01
Pages (from-to)S3-S3
Number of pages1
JournalSupportive Care in Cancer
Volume30
Issue numberS1
Publication statusPublished - 1 Jun 2022
Event2022 MASCC/ISOO Annual Meeting on Supportive Care in Cancer - Canada, Toronto, Canada
Duration: 23 Jun 202225 Jun 2022
https://mascc.org/meetings/past-meetings/2022-meeting-highlights/2022-annual-meeting-presentations/

Fingerprint

Dive into the research topics of 'Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial'. Together they form a unique fingerprint.

Cite this